Report Detail
Global Orphan Drugs Market Professional Survey Report 2019
- RnM2953809 |
- 17 July, 2020 |
- Global |
- 149 Pages |
- QYResearch |
- Pharma & Healthcare
Orphan Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Orphan Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Orphan Drugs market is segmented into
Oncology
Gastrointestinal
Pulmonary
Neurology
Hematology
Cardio-vascular
Metabolic disorders
Endocrinology
Infectious diseases
Others
Segment by Application, the Orphan Drugs market is segmented into
Hospital Pharmacies
Speciality Pharmacies
Retail pharmacies
Others
Regional and Country-level Analysis
The Orphan Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Orphan Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Orphan Drugs Market Share Analysis
Orphan Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Orphan Drugs business, the date to enter into the Orphan Drugs market, Orphan Drugs product introduction, recent developments, etc.
The major vendors covered:
Novartis AG
Bristol-Myers Squibb Company
Celgene Corporation
F. Hoffmann-La Roche Ltd.
Pfizer, Inc.
Sanofi S.A.
Alexion Pharmaceuticals, Inc.
Eli Lilly and Company
Novo Nordisk A/S
AstraZeneca
Eisai Co., Ltd.
Daiichi Sankyo Company Limited
Bayer AG
GlaxoSmithKline
Merck & Co., Inc.
Johnson & Johnson
Biogen, Inc.
Takeda
Amgen, Inc.
1 Study Coverage
- 1.1 Orphan Drugs Product Introduction
- 1.2 Market Segments
- 1.3 Key Orphan Drugs Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Orphan Drugs Market Size Growth Rate by Type
- 1.4.2 Oncology
- 1.4.3 Gastrointestinal
- 1.4.4 Pulmonary
- 1.4.5 Neurology
- 1.4.6 Hematology
- 1.4.7 Cardio-vascular
- 1.4.8 Metabolic disorders
- 1.4.9 Endocrinology
- 1.4.10 Infectious diseases
- 1.4.11 Others
- 1.5 Market by Application
- 1.5.1 Global Orphan Drugs Market Size Growth Rate by Application
- 1.5.2 Hospital Pharmacies
- 1.5.3 Speciality Pharmacies
- 1.5.4 Retail pharmacies
- 1.5.5 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Orphan Drugs Market Size, Estimates and Forecasts
- 2.1.1 Global Orphan Drugs Revenue 2015-2026
- 2.1.2 Global Orphan Drugs Sales 2015-2026
- 2.2 Global Orphan Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Orphan Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Orphan Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Orphan Drugs Competitor Landscape by Players
- 3.1 Orphan Drugs Sales by Manufacturers
- 3.1.1 Orphan Drugs Sales by Manufacturers (2015-2020)
- 3.1.2 Orphan Drugs Sales Market Share by Manufacturers (2015-2020)
- 3.2 Orphan Drugs Revenue by Manufacturers
- 3.2.1 Orphan Drugs Revenue by Manufacturers (2015-2020)
- 3.2.2 Orphan Drugs Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Orphan Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Orphan Drugs Revenue in 2019
- 3.2.5 Global Orphan Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Orphan Drugs Price by Manufacturers
- 3.4 Orphan Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Orphan Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Orphan Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Orphan Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Orphan Drugs Market Size by Type (2015-2020)
- 4.1.1 Global Orphan Drugs Sales by Type (2015-2020)
- 4.1.2 Global Orphan Drugs Revenue by Type (2015-2020)
- 4.1.3 Orphan Drugs Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Orphan Drugs Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Orphan Drugs Sales Forecast by Type (2021-2026)
- 4.2.2 Global Orphan Drugs Revenue Forecast by Type (2021-2026)
- 4.2.3 Orphan Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Orphan Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Orphan Drugs Market Size by Application (2015-2020)
- 5.1.1 Global Orphan Drugs Sales by Application (2015-2020)
- 5.1.2 Global Orphan Drugs Revenue by Application (2015-2020)
- 5.1.3 Orphan Drugs Price by Application (2015-2020)
- 5.2 Orphan Drugs Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Orphan Drugs Sales Forecast by Application (2021-2026)
- 5.2.2 Global Orphan Drugs Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Orphan Drugs Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Orphan Drugs by Country
- 6.1.1 North America Orphan Drugs Sales by Country
- 6.1.2 North America Orphan Drugs Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Orphan Drugs Market Facts & Figures by Type
- 6.3 North America Orphan Drugs Market Facts & Figures by Application
7 Europe
- 7.1 Europe Orphan Drugs by Country
- 7.1.1 Europe Orphan Drugs Sales by Country
- 7.1.2 Europe Orphan Drugs Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Orphan Drugs Market Facts & Figures by Type
- 7.3 Europe Orphan Drugs Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Orphan Drugs by Region
- 8.1.1 Asia Pacific Orphan Drugs Sales by Region
- 8.1.2 Asia Pacific Orphan Drugs Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Orphan Drugs Market Facts & Figures by Type
- 8.3 Asia Pacific Orphan Drugs Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Orphan Drugs by Country
- 9.1.1 Latin America Orphan Drugs Sales by Country
- 9.1.2 Latin America Orphan Drugs Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Orphan Drugs Market Facts & Figures by Type
- 9.3 Central & South America Orphan Drugs Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Orphan Drugs by Country
- 10.1.1 Middle East and Africa Orphan Drugs Sales by Country
- 10.1.2 Middle East and Africa Orphan Drugs Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Orphan Drugs Market Facts & Figures by Type
- 10.3 Middle East and Africa Orphan Drugs Market Facts & Figures by Application
11 Company Profiles
- 11.1 Novartis AG
- 11.1.1 Novartis AG Corporation Information
- 11.1.2 Novartis AG Description and Business Overview
- 11.1.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Novartis AG Orphan Drugs Products Offered
- 11.1.5 Novartis AG Related Developments
- 11.2 Bristol-Myers Squibb Company
- 11.2.1 Bristol-Myers Squibb Company Corporation Information
- 11.2.2 Bristol-Myers Squibb Company Description and Business Overview
- 11.2.3 Bristol-Myers Squibb Company Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Bristol-Myers Squibb Company Orphan Drugs Products Offered
- 11.2.5 Bristol-Myers Squibb Company Related Developments
- 11.3 Celgene Corporation
- 11.3.1 Celgene Corporation Corporation Information
- 11.3.2 Celgene Corporation Description and Business Overview
- 11.3.3 Celgene Corporation Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Celgene Corporation Orphan Drugs Products Offered
- 11.3.5 Celgene Corporation Related Developments
- 11.4 F. Hoffmann-La Roche Ltd.
- 11.4.1 F. Hoffmann-La Roche Ltd. Corporation Information
- 11.4.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
- 11.4.3 F. Hoffmann-La Roche Ltd. Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 F. Hoffmann-La Roche Ltd. Orphan Drugs Products Offered
- 11.4.5 F. Hoffmann-La Roche Ltd. Related Developments
- 11.5 Pfizer, Inc.
- 11.5.1 Pfizer, Inc. Corporation Information
- 11.5.2 Pfizer, Inc. Description and Business Overview
- 11.5.3 Pfizer, Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Pfizer, Inc. Orphan Drugs Products Offered
- 11.5.5 Pfizer, Inc. Related Developments
- 11.6 Sanofi S.A.
- 11.6.1 Sanofi S.A. Corporation Information
- 11.6.2 Sanofi S.A. Description and Business Overview
- 11.6.3 Sanofi S.A. Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Sanofi S.A. Orphan Drugs Products Offered
- 11.6.5 Sanofi S.A. Related Developments
- 11.7 Alexion Pharmaceuticals, Inc.
- 11.7.1 Alexion Pharmaceuticals, Inc. Corporation Information
- 11.7.2 Alexion Pharmaceuticals, Inc. Description and Business Overview
- 11.7.3 Alexion Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Alexion Pharmaceuticals, Inc. Orphan Drugs Products Offered
- 11.7.5 Alexion Pharmaceuticals, Inc. Related Developments
- 11.8 Eli Lilly and Company
- 11.8.1 Eli Lilly and Company Corporation Information
- 11.8.2 Eli Lilly and Company Description and Business Overview
- 11.8.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Eli Lilly and Company Orphan Drugs Products Offered
- 11.8.5 Eli Lilly and Company Related Developments
- 11.9 Novo Nordisk A/S
- 11.9.1 Novo Nordisk A/S Corporation Information
- 11.9.2 Novo Nordisk A/S Description and Business Overview
- 11.9.3 Novo Nordisk A/S Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Novo Nordisk A/S Orphan Drugs Products Offered
- 11.9.5 Novo Nordisk A/S Related Developments
- 11.10 AstraZeneca
- 11.10.1 AstraZeneca Corporation Information
- 11.10.2 AstraZeneca Description and Business Overview
- 11.10.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 AstraZeneca Orphan Drugs Products Offered
- 11.10.5 AstraZeneca Related Developments
- 11.1 Novartis AG
- 11.1.1 Novartis AG Corporation Information
- 11.1.2 Novartis AG Description and Business Overview
- 11.1.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Novartis AG Orphan Drugs Products Offered
- 11.1.5 Novartis AG Related Developments
- 11.12 Daiichi Sankyo Company Limited
- 11.12.1 Daiichi Sankyo Company Limited Corporation Information
- 11.12.2 Daiichi Sankyo Company Limited Description and Business Overview
- 11.12.3 Daiichi Sankyo Company Limited Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 Daiichi Sankyo Company Limited Products Offered
- 11.12.5 Daiichi Sankyo Company Limited Related Developments
- 11.13 Bayer AG
- 11.13.1 Bayer AG Corporation Information
- 11.13.2 Bayer AG Description and Business Overview
- 11.13.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
- 11.13.4 Bayer AG Products Offered
- 11.13.5 Bayer AG Related Developments
- 11.14 GlaxoSmithKline
- 11.14.1 GlaxoSmithKline Corporation Information
- 11.14.2 GlaxoSmithKline Description and Business Overview
- 11.14.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
- 11.14.4 GlaxoSmithKline Products Offered
- 11.14.5 GlaxoSmithKline Related Developments
- 11.15 Merck & Co., Inc.
- 11.15.1 Merck & Co., Inc. Corporation Information
- 11.15.2 Merck & Co., Inc. Description and Business Overview
- 11.15.3 Merck & Co., Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.15.4 Merck & Co., Inc. Products Offered
- 11.15.5 Merck & Co., Inc. Related Developments
- 11.16 Johnson & Johnson
- 11.16.1 Johnson & Johnson Corporation Information
- 11.16.2 Johnson & Johnson Description and Business Overview
- 11.16.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
- 11.16.4 Johnson & Johnson Products Offered
- 11.16.5 Johnson & Johnson Related Developments
- 11.17 Biogen, Inc.
- 11.17.1 Biogen, Inc. Corporation Information
- 11.17.2 Biogen, Inc. Description and Business Overview
- 11.17.3 Biogen, Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.17.4 Biogen, Inc. Products Offered
- 11.17.5 Biogen, Inc. Related Developments
- 11.18 Takeda
- 11.18.1 Takeda Corporation Information
- 11.18.2 Takeda Description and Business Overview
- 11.18.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
- 11.18.4 Takeda Products Offered
- 11.18.5 Takeda Related Developments
- 11.19 Amgen, Inc.
- 11.19.1 Amgen, Inc. Corporation Information
- 11.19.2 Amgen, Inc. Description and Business Overview
- 11.19.3 Amgen, Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.19.4 Amgen, Inc. Products Offered
- 11.19.5 Amgen, Inc. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Orphan Drugs Market Estimates and Projections by Region
- 12.1.1 Global Orphan Drugs Sales Forecast by Regions 2021-2026
- 12.1.2 Global Orphan Drugs Revenue Forecast by Regions 2021-2026
- 12.2 North America Orphan Drugs Market Size Forecast (2021-2026)
- 12.2.1 North America: Orphan Drugs Sales Forecast (2021-2026)
- 12.2.2 North America: Orphan Drugs Revenue Forecast (2021-2026)
- 12.2.3 North America: Orphan Drugs Market Size Forecast by Country (2021-2026)
- 12.3 Europe Orphan Drugs Market Size Forecast (2021-2026)
- 12.3.1 Europe: Orphan Drugs Sales Forecast (2021-2026)
- 12.3.2 Europe: Orphan Drugs Revenue Forecast (2021-2026)
- 12.3.3 Europe: Orphan Drugs Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Orphan Drugs Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Orphan Drugs Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Orphan Drugs Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Orphan Drugs Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Orphan Drugs Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Orphan Drugs Sales Forecast (2021-2026)
- 12.5.2 Latin America: Orphan Drugs Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Orphan Drugs Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Orphan Drugs Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Orphan Drugs Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Orphan Drugs Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Orphan Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Orphan Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Orphan Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Orphan Drugs . Industry analysis & Market Report on Orphan Drugs is a syndicated market report, published as Global Orphan Drugs Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Orphan Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
